As of Mar 27
| +2.15 / +3.56%|
The 11 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 81.00, with a high estimate of 135.00 and a low estimate of 65.00. The median estimate represents a +29.35% increase from the last price of 62.62.
The current consensus among 11 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.